Skip to main content

Search

Reset all filters
565 Result(s)
Sort by

clinical_collaboration_with_Mirati

clinical_collaboration_with_Mirati

Boehringer Ingelheim and Mirati are teaming up in a clinical collaboration to evaluate the combination of the SOS1::pan-KRAS and the selective G12C inhibitor.
Ingelheim

Ingelheim

The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany.
FDA-Fast-Track-chronic-kidney-disease

FDA-Fast-Track-chronic-kidney-disease

FDA grants Fast Track designation for the treatment of chronic kidney disease, underscoring urgent need for new treatments for people living with the condition
Women in the workplace: Inspiring inclusion

Women in the workplace: Inspiring inclusion

On International Women’s Day, we address the critical role of women in our society and ensure their voice is heard at all levels of our organization.
Questions and Answers

Questions and Answers

Answers to common questions from both patients and health care professionals regarding Compassionate Use of experimental medications.
1885-1948: Innovative beginnings

1885-1948: Innovative beginnings

The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products
2019 performance

2019 performance

Global Support Program addresses COVID-19 crisis with relief fund initiatives and volunteering support, donations, and concrete research activities.
More Potential Overview

More Potential Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Living with heart failure

Living with heart failure

Hear Patricia’s story on the impact that heart failure can have on mental health and the importance of finding support networks.
BI_X_Shanghai

BI_X_Shanghai

Boehringer Ingelheim opens a second branch of its digital lab in Shanghai